Pulmonary Surfactant Protein A Regulates TLR Expression and Activity in Human Macrophages
Overview
Authors
Affiliations
The pulmonary innate immune system responds to various airborne microbes. Although its specificity is broad and based on the recognition of pathogen-associated molecular patterns, it is uniquely regulated to limit inflammation and thereby prevent damage to the gas-exchanging alveoli. Macrophages, critical cell determinants of this system, recognize microbes through pattern recognition receptors such as TLRs, which typically mediate proinflammatory responses. The lung collectin, surfactant protein A (SP-A), has emerged as an important innate immune determinant that regulates microbe-macrophage interactions in this environment. In this study, we report the basal and SP-A-induced transcriptional and posttranslational regulation of TLR2 and TLR4 expression during the differentiation of primary human monocytes into macrophages. Despite SP-A's ability to up-regulate TLR2 expression on human macrophages, it dampens TLR2 and TLR4 signaling in these cells. SP-A decreases the phosphorylation of IkappaBalpha, a key regulator of NF-kappaB activity, and nuclear translocation of p65 which result in diminished TNF-alpha secretion in response to TLR ligands. SP-A also reduces the phosphorylation of TLR signaling proteins upstream of NF-kappaB, including members of the MAPK family. Finally, we report for the first time that SP-A decreases the phosphorylation of Akt, a major cell regulator of NF-kappaB and potentially MAPKs. These data identify a critical role for SP-A in modulating the lung inflammatory response by regulating macrophage TLR activity.
Zhou Q, Xiong H, Wu H, Wang C, Chen X, Liu H Poult Sci. 2025; 104(3):104854.
PMID: 39879901 PMC: 11815655. DOI: 10.1016/j.psj.2025.104854.
Surfactant protein a attenuates generalized and localized neuroinflammation in neonatal mice.
Crocker C, Sharmeen R, Tran T, Khan A, Li W, Alcorn J Brain Res. 2023; 1807:148308.
PMID: 36871846 PMC: 10065943. DOI: 10.1016/j.brainres.2023.148308.
Al-Sayyar A, Hulme K, Thibaut R, Bayry J, Sheedy F, Short K Front Endocrinol (Lausanne). 2022; 13:919223.
PMID: 35957811 PMC: 9363013. DOI: 10.3389/fendo.2022.919223.
Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A.
Toyama C, Maeda A, Kogata S, Yamamoto R, Masahata K, Ueno T Exp Ther Med. 2022; 24(3):590.
PMID: 35949334 PMC: 9353545. DOI: 10.3892/etm.2022.11527.
Phelps D, Chinchilli V, Zhang X, Shearer D, Weisz J, Floros J Front Immunol. 2022; 13:853611.
PMID: 35572576 PMC: 9094576. DOI: 10.3389/fimmu.2022.853611.